Page last updated: 2024-10-28

bis(2-guanidinoethyl)disulfide and Multiple Sclerosis

bis(2-guanidinoethyl)disulfide has been researched along with Multiple Sclerosis in 1 studies

bis(2-guanidinoethyl)disulfide: bifunctional cation; RN given refers to parent cpd; structure

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scott, GS1
Kean, RB1
Southan, GJ1
Szabó, C1
Hooper, DC1

Other Studies

1 other study available for bis(2-guanidinoethyl)disulfide and Multiple Sclerosis

ArticleYear
Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice.
    Neuroscience letters, 2001, Sep-28, Volume: 311, Issue:2

    Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Fem

2001